• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前治疗性血液成分单采术治疗严重药物难治性胺碘酮所致甲状腺毒症:一例报告

Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report.

作者信息

Yamamoto Jennifer, Dostmohamed Hanifa, Schacter Isanne, Ariano Robert E, Houston Donald S, Lewis Brenda, Knoll Colleen, Katz Pamela, Zarychanski Ryan

机构信息

Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

J Clin Apher. 2014 Jun;29(3):168-70. doi: 10.1002/jca.21309. Epub 2013 Nov 22.

DOI:10.1002/jca.21309
PMID:24265247
Abstract

INTRODUCTION

Amiodarone is associated with thyroid dysfunction and life-threatening thyrotoxicosis. In medically refractory cases, or where medical therapy is contraindicated, thyroidectomy may be required. To decrease perioperative thyroid storm and to reduce overall surgical risk, apheresis may be considered preoperatively to restore euthyroidism.

CASE DESCRIPTION

We report a 46-year-old female with a history of cardiac arrhythmia and tachycardia-induced cardiomyopathy for which she received amiodarone. Months after discontinuation of amiodarone, the patient presented with wide complex tachycardia and symptoms of thyrotoxicosis. Laboratory testing confirmed severe thyrotoxicosis which was subsequently refractory to medical therapy. Total thyroidectomy was required. Following a total of 10 apheresis treatments, thyroid hormone levels were reduced to near normal levels and the patient's symptoms improved. Thyroidectomy was performed without intraoperative or postoperative complication.

DISCUSSION

In the setting of life-threatening, medically refractory amiodarone-induced thyrotoxicosis, therapeutic apheresis can effectively reduce thyroid hormone levels and restore a state of clinical and biochemical euthyroidism.

摘要

引言

胺碘酮与甲状腺功能障碍及危及生命的甲状腺毒症有关。在药物治疗无效的情况下,或药物治疗禁忌时,可能需要进行甲状腺切除术。为减少围手术期甲状腺风暴并降低总体手术风险,术前可考虑进行血液成分单采以恢复甲状腺功能正常。

病例描述

我们报告一名46岁女性,有心脏心律失常和心动过速性心肌病病史,为此接受了胺碘酮治疗。停用胺碘酮数月后,患者出现宽QRS波心动过速和甲状腺毒症症状。实验室检查证实为严重甲状腺毒症,随后药物治疗无效。需要进行全甲状腺切除术。总共进行10次血液成分单采治疗后,甲状腺激素水平降至接近正常水平,患者症状改善。甲状腺切除术未出现术中或术后并发症。

讨论

在危及生命、药物治疗无效的胺碘酮所致甲状腺毒症情况下,治疗性血液成分单采可有效降低甲状腺激素水平并恢复临床和生化甲状腺功能正常状态。

相似文献

1
Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report.术前治疗性血液成分单采术治疗严重药物难治性胺碘酮所致甲状腺毒症:一例报告
J Clin Apher. 2014 Jun;29(3):168-70. doi: 10.1002/jca.21309. Epub 2013 Nov 22.
2
Drug-induced thyrotoxicosis: the surgical option.药物性甲状腺毒症:手术治疗方案
Isr Med Assoc J. 2007 Feb;9(2):79-82.
3
Total thyroidectomy in amiodarone-induced thyrotoxicosis. Preoperative, intraoperative and postoperative considerations.胺碘酮所致甲状腺毒症的甲状腺全切除术。术前、术中和术后注意事项。
Eur Rev Med Pharmacol Sci. 2006 Jul-Aug;10(4):187-90.
4
[Amiodarone-induced thyrotoxicosis cured by thyroidectomy].[甲状腺切除术治愈胺碘酮所致甲状腺毒症]
Ann Fr Anesth Reanim. 1996;15(7):1092-4. doi: 10.1016/s0750-7658(96)89481-0.
5
An audit of amiodarone-induced thyrotoxicosis--do anti-thyroid drugs alone provide adequate treatment?胺碘酮所致甲状腺毒症的审计——仅使用抗甲状腺药物是否能提供充分治疗?
Heart Lung Circ. 2014 Jun;23(6):549-54. doi: 10.1016/j.hlc.2014.01.013. Epub 2014 Feb 7.
6
Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation?胺碘酮相关性甲状腺毒症的全甲状腺切除术:手术是否总是应推迟进行术前药物准备?
J Laryngol Otol. 2012 Jul;126(7):701-5. doi: 10.1017/S0022215112000722. Epub 2012 May 22.
7
Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy.胺碘酮所致甲状腺毒症:临床表现及甲状腺切除术的扩展适应证
Surgery. 1993 Dec;114(6):1114-9.
8
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.胺碘酮所致甲状腺毒症合并严重心脏疾病患者的微创甲状腺手术联合局部麻醉与碘番酸:一项初步研究
Langenbecks Arch Surg. 2007 Nov;392(6):709-13. doi: 10.1007/s00423-006-0112-y. Epub 2006 Nov 14.
9
[Subtotal thyroidectomy. A treatment to keep in mind in amiodarone-induced thyrotoxicosis].[甲状腺次全切除术。胺碘酮所致甲状腺毒症中值得考虑的一种治疗方法]
Rev Esp Cardiol. 1996 Jun;49(6):474-6.
10
Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy.难治性胺碘酮相关性甲状腺毒症:甲状腺切除术的一个指征。
Aust N Z J Surg. 2000 Mar;70(3):174-8. doi: 10.1046/j.1440-1622.2000.01780.x.

引用本文的文献

1
Exploring the role of plasmapheresis prior to thyroidectomy in managing thyrotoxicosis: a comprehensive scoping review.探索甲状腺切除术前血浆置换在治疗甲状腺毒症中的作用:一项全面的范围综述。
J Artif Organs. 2025 Jun;28(2):146-153. doi: 10.1007/s10047-024-01476-6. Epub 2024 Oct 10.
2
THERAPEUTIC PLASMA EXCHANGE AS A BRIDGE TO TOTAL THYROIDECTOMY IN PATIENTS WITH SEVERE THYROTOXICOSIS.治疗性血浆置换作为重度甲状腺毒症患者行全甲状腺切除术的桥梁。
AACE Clin Case Rep. 2020 Sep 26;6(1):e14-e18. doi: 10.4158/ACCR-2019-0132. eCollection 2020 Jan-Feb.
3
Management of Amiodarone-Induced Thyrotoxicosis at a Cardiac Transplantation Centre.
心脏移植中心胺碘酮所致甲状腺毒症的管理
Front Endocrinol (Lausanne). 2018 Aug 22;9:482. doi: 10.3389/fendo.2018.00482. eCollection 2018.
4
Therapeutic plasmapheresis in thyrotoxic patients.甲状腺毒症患者的治疗性血浆置换。
Endocrine. 2018 Oct;62(1):144-148. doi: 10.1007/s12020-018-1661-x. Epub 2018 Jul 2.
5
Interferon alpha-induced non-immune thyrotoxicosis treated by plasmapheresis.血浆置换治疗干扰素α诱导的非免疫性甲状腺毒症。
BMJ Case Rep. 2017 Sep 25;2017:bcr-2017-221228. doi: 10.1136/bcr-2017-221228.